NCT00312130View on ClinicalTrials.gov

A Study to Evaluate the Effects of Vildagliptin on the Insulin Response to Glucose in Subjects With Pre-diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

November 30, 2006

Study Completion Date

November 30, 2006

Conditions
Pre-diabetes
Interventions
DRUG

Vildagliptin

Trial Locations (1)

98108

University of Washington, Seattle

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY

NCT00312130 - A Study to Evaluate the Effects of Vildagliptin on the Insulin Response to Glucose in Subjects With Pre-diabetes | Biotech Hunter | Biotech Hunter